Cedar Wealth Management, LLC - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 83 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cedar Wealth Management, LLC ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$1,0000.0%5,0000.0%0.00%
Q1 2022$1,000
-66.7%
5,0000.0%0.00%
-100.0%
Q4 2021$3,000
-40.0%
5,0000.0%0.00%
-50.0%
Q3 2021$5,000
-28.6%
5,0000.0%0.00%
-33.3%
Q2 2021$7,000
-22.2%
5,0000.0%0.00%
-25.0%
Q1 2021$9,000
-52.6%
5,000
-66.7%
0.00%
-60.0%
Q4 2020$19,000
-9.5%
15,0000.0%0.01%
-23.1%
Q3 2020$21,000
+16.7%
15,0000.0%0.01%
+8.3%
Q2 2020$18,0000.0%15,0000.0%0.01%0.0%
Q1 2020$18,000
-43.8%
15,0000.0%0.01%
-36.8%
Q4 2019$32,000
-68.6%
15,000
-67.7%
0.02%
-72.1%
Q3 2019$102,000
-12.8%
46,3950.0%0.07%
-10.5%
Q2 2019$117,000
-27.3%
46,3950.0%0.08%
-24.8%
Q1 2019$161,000
+50.5%
46,3950.0%0.10%
+31.2%
Q4 2018$107,000
-17.7%
46,395
+36.9%
0.08%
+13.2%
Q3 2018$130,000
+217.1%
33,895
+182.5%
0.07%
+195.7%
Q2 2018$41,000
+95.2%
12,000
+20.0%
0.02%
+76.9%
Q1 2018$21,000
+5.0%
10,0000.0%0.01%
+8.3%
Q4 2017$20,00010,0000.01%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Perceptive Advisors 6,574,060$27,874,0001.68%
SENZAR ASSET MANAGEMENT, LLC 798,381$3,385,0000.58%
Cormorant Asset Management, LP 850,000$3,604,0000.48%
Palo Alto Investors LP 2,135,739$9,056,0000.40%
Opus Point Partners Management, LLC 99,959$424,0000.34%
Granahan Investment Management 1,582,237$6,709,0000.19%
Joel Isaacson & Co., LLC 70,660$300,0000.08%
MARINER INVESTMENT GROUP LLC 59,700$253,0000.06%
MYCIO WEALTH PARTNERS, LLC 75,000$318,0000.06%
Cornerstone Capital, Inc. 59,200$251,0000.06%
View complete list of ACELRX PHARMACEUTICALS INC shareholders